---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-091795"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T08:53:46.759750+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Oramed receives ~$1M prepayment on Scilex Tranche A Note; outstanding reduced to $80.2M

## Summary
- Received ~$1,000,000 mandatory prepayment on Tranche A Note from Scilex on Oct 24, 2024.
- After payment, $80,200,000 of original $101.875M principal repaid or refinanced.
- Payment represents 70% of net cash proceeds from Scilex debt/equity financings.
- Original Tranche A Note issued Sep 2023; $22.5M exchanged for Tranche B Notes in Oct 2024.
- $2.5M of principal exchanged for royalty purchase agreement interest.

## SEC filing metadata
- accession: 0001213900-24-091795
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024091795/0001213900-24-091795-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024091795/ea0219080-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-091795
- JSON: https://secwatch.observer/filing/0001213900-24-091795.json
- Plain text: https://secwatch.observer/filing/0001213900-24-091795.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.